These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 57567)

  • 1. [Antiarrhythmic treatment of ventricular ectropic arrhythmies with Disopyramide].
    Olbermann M; Just H; Guckenbiehl H; Lang KF
    Med Klin; 1976 Apr; 71(14):593-8. PubMed ID: 57567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) (author's transl)].
    Smith WS
    Herz; 1978 Dec; 63(36):399-406. PubMed ID: 95482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation].
    Breithardt G; Haerten K; Seipel L
    Z Kardiol; 1976 Aug; 65(8):713-23. PubMed ID: 61664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiarrhythmic action of disopyramide: a study of plasma levels].
    Page A; Pic A; Besse P
    Arch Mal Coeur Vaiss; 1979 Jul; 72(7):774-80. PubMed ID: 117775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disopyramide-induced ventricular tachycardia.
    Lo KS; Gantz KB; Stetson PL; Lucchesi BR; Pitt B
    Arch Intern Med; 1980 Mar; 140(3):413-4. PubMed ID: 6153888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral longterm therapy with disopyramide phosphate in patients with atrial and ventricular arrhythmias (author's transl)].
    Stauch M; Grewe N
    MMW Munch Med Wochenschr; 1977 Dec; 119(48):1563-6. PubMed ID: 74799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of quinidine and disopyramide in the treatment of stable ventricular extrasystole].
    Barnay C; Medvedowsky JL; Clémenty J; Bricaud H; Pellet J; Denis B; Machecourt J; Wolf JE; Dimitrio R; Egre A
    Arch Mal Coeur Vaiss; 1983 Aug; 76(8):909-17. PubMed ID: 6194768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiarrhythmic effect of disopyramid retard versus propranolol retard in ventricular extrasystole].
    Fechter P; Nager F
    Schweiz Med Wochenschr; 1982 Dec; 112(51):1897-900. PubMed ID: 6187065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamic electrocardiography evaluation of the effectiveness of prajmalium bitartrate, disopyramide and procainamide in patients with stabilized ventricular extrasystole].
    Naccarella F; Del Corso P; Palmieri M; Cantelli I; Lentini G; Bracchetti D
    G Ital Cardiol; 1981; 11(3):338-44. PubMed ID: 6169577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
    Vogel M; Desoutter P; Bellanger P; Motté G; Welti JJ
    Arch Mal Coeur Vaiss; 1976 Apr; 69(4):395-406. PubMed ID: 59581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the efficacy of moricizine and disopyramide in the treatment of ventricular extrasystoles].
    Fauchier JP; Babuty D; Rouesnel P; Cosnay P; Estepo J
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):553-60. PubMed ID: 1712193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of disopyramide and atenolol in the therapy of stabilized ventricular extrasystole in patients with mitral valve prolapse].
    Capucci A; Naccarella F; Catena G; Lamberti C; Marchesini B; Bracchetti D; Magnani B
    G Ital Cardiol; 1981; 11(4):498-505. PubMed ID: 6169581
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of ventricular tachyarrhythmia with disopyramid phosphate].
    Steinbrunn W; Mattmann H; Enrico JF; Engel U
    Schweiz Med Wochenschr; 1980 Jun; 110(24):953-7. PubMed ID: 7414314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disopyramide in the treatment of ventricular extrasystole in chronic Chagas' disease].
    Albanesi Filho FM; da Rocha PJ; Benchimol CB; Ginefra P; Benchimol AB
    Arq Bras Cardiol; 1979 Dec; 33(6):453-8. PubMed ID: 95160
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
    Tanabe T; Takahashi K; Yoshioka K; Goto Y
    Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proceedings: Antiarrhytmic effects of Disopyramide].
    Olbermann M; Just H; Guckenbiehl H; Lang KF
    MMW Munch Med Wochenschr; 1975 May; 117(20):838. PubMed ID: 49014
    [No Abstract]   [Full Text] [Related]  

  • 20. Disopyramide: clinical indications, pharmacokinetics and laboratory assessment.
    Taylor EH; Pappas AA
    Ann Clin Lab Sci; 1986; 16(4):289-95. PubMed ID: 2427003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.